Matinas BioPharma Holdings, Inc.
MTNB- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001582554
No open-market purchases or sales by Matinas BioPharma Holdings, Inc. insiders were filed in the last 90 days; 25 institutions reported holding it in 13F filings for Q2 2026, worth $199.2K in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding Matinas BioPharma Holdings, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Of which not filed for Q4 2021 | Q4 2021 | Change |
|---|---|---|---|---|
| Holders | 67 | 1 | 66 | 0 |
| Shares | 25.7M | 24.0K | 27.1M | +1.38M (+5.4%) |
| Value | $33.5M | $31.0K | $27.4M | −$6.08M (−18.2%) |
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (11)
Institutions that held Matinas BioPharma Holdings, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna International Group, LLP | 59,570 | $60.0K | 0.00% |
| Qube Research & Technologies Ltd | 59,523 | $60.0K | 0.00% |
| Goldman Sachs Group Inc | 46,457 | $47.0K | 0.00% |
| Mirabella Financial Services LLP | 45,100 | $46.0K | 0.00% |
| Rafferty Asset Management, LLC | 34,402 | $35.0K | 0.00% |
| National Wealth Management Group, LLC | 23,900 | $24.1K | 0.02% |
| Occidental Asset Management, LLC | 20,000 | $20.0K | 0.00% |
| Raymond James & Associates | 13,500 | $14.0K | 0.00% |
| AE Wealth Management LLC | 11,889 | $12.0K | 0.00% |
| Citigroup Inc | 178 | $0 | 0.00% |
| Cornerstone Advisory, LLC | 50 | $0 | 0.00% |
Sold out (11)
Institutions that held Matinas BioPharma Holdings, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Gsa Capital Partners LLP | 744,024 | $967.0K |
| Price T Rowe Associates Inc | 169,800 | $221.0K |
| Jane Street Group, LLC | 162,141 | $211.0K |
| Tower Research Capital LLC (TRC) | 45,936 | $60.0K |
| Winton Group Ltd | 31,701 | $41.0K |
| Manufacturers Life Insurance Company, The | 18,954 | $25.0K |
| Resources Investment Advisors, LLC. | 18,000 | $23.0K |
| Perkins Capital Management Inc | 14,500 | $19.0K |
| Avantax Advisory Services, Inc. | 10,000 | $13.0K |
| UBS Group AG | 10,294 | $13.0K |
| Endurance Wealth Management, Inc. | 6,750 | $9.00K |
Not filed for Q4 2021 yet (1)
Institutions that held Matinas BioPharma Holdings, Inc. at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| BFT Financial Group, LLC | 24,000 | $31.0K |